WallStreetZenWallStreetZen

NASDAQ: GEVO
Gevo Inc Stock Forecast, Predictions & Price Target

Analyst price target for GEVO

Based on 3 analysts offering 12 month price targets for Gevo Inc.
Min Forecast
$0.85+41.2%
Avg Forecast
$5.68+844.02%
Max Forecast
$14.00+2,225.58%

Should I buy or sell GEVO stock?

Based on 3 analysts offering ratings for Gevo Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GEVO stock forecasts and price targets.

GEVO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-08
lockedlocked$00.00+00.00%2023-11-27

1 of 1

Forecast return on equity

Is GEVO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is GEVO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

GEVO revenue forecast

What is GEVO's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$19.9M+15.41%
Avg 2 year Forecast
$31.2M+81.66%
Avg 3 year Forecast
$41.9M+143.49%
GEVO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GEVO revenue growth forecast

How is GEVO forecast to perform vs Specialty Chemicals companies and vs the US market?
Company
34.72%
Industry
-5.1%
Market
10.23%
GEVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GEVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GEVO vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
GEVO$0.60$5.68+844.02%Buy
ALTO$1.91$5.00+161.78%Buy
NTIC$15.43$20.00+29.62%Buy
LOOP$2.66N/AN/A
CMT$19.04$25.50+33.93%Strong Buy

Gevo Stock Forecast FAQ

Is Gevo Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: GEVO) stock is to Buy GEVO stock.

Out of 3 analysts, 1 (33.33%) are recommending GEVO as a Strong Buy, 1 (33.33%) are recommending GEVO as a Buy, 1 (33.33%) are recommending GEVO as a Hold, 0 (0%) are recommending GEVO as a Sell, and 0 (0%) are recommending GEVO as a Strong Sell.

If you're new to stock investing, here's how to buy Gevo stock.

What is GEVO's revenue growth forecast for 2024-2026?

(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 34.72% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of -5.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Gevo's revenue in 2024 is $17,200,000.On average, 3 Wall Street analysts forecast GEVO's revenue for 2024 to be $4,773,921,685, with the lowest GEVO revenue forecast at $4,569,496,827, and the highest GEVO revenue forecast at $4,990,371,535. On average, 3 Wall Street analysts forecast GEVO's revenue for 2025 to be $7,514,657,782, with the lowest GEVO revenue forecast at $5,771,995,992, and the highest GEVO revenue forecast at $8,494,454,102.

In 2026, GEVO is forecast to generate $10,072,133,006 in revenue, with the lowest revenue forecast at $5,771,995,992 and the highest revenue forecast at $14,372,270,020.

What is GEVO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GEVO) forecast ROA is N/A, which is lower than the forecast US Specialty Chemicals industry average of N/A.

What is GEVO's Price Target?

According to 3 Wall Street analysts that have issued a 1 year GEVO price target, the average GEVO price target is $5.68, with the highest GEVO stock price forecast at $14.00 and the lowest GEVO stock price forecast at $0.85.

On average, Wall Street analysts predict that Gevo's share price could reach $5.68 by Apr 10, 2025. The average Gevo stock price prediction forecasts a potential upside of 844.02% from the current GEVO share price of $0.60.

What is GEVO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GEVO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.